Introduction
A New Treatment in Alopecia Areata
Objectives
•Establish that AA is an autoimmune condition with a high impact on patient quality of life beyond hair loss.
•Discuss the limitations of current therapies and learn about the MOA of Olumiant in AA.
•Efficacy and safety data in patients with severe AA, and how to initiate and monitor patients on Olumiant.
This Course For :
Physician
( Dermatology , Family Medicine , Internal Medicine )
Resident / Fellow
( Dermatology , Family Medicine , Internal Medicine )
Speaker
Dr. Sergio Vañó Galván (MD, PhD)
Dermatologist, trichologist, hair surgeon, and Director of the Trichology Unit
of the Ramón y Cajal University Hospital and the Trichology and Hair
Transplant Unit of Pedro Jaén Group Clinic, in Madrid. He is the Director of
the international master’s degree in Trichology and Hair Transplantation at the
University of Alcalá.
Prof. Bianca Maria Piraccini(MD, PhD)
Professor and Head of the Dermatology Department at the University of
Bologna, Italy. She acts as a board member of Società Italiana di
Dermatologia e Malattie Sessualmente Trasmesse (SIDeMaST) and Council
for Nail Disorders (CND).
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
06 Sep 2023 To 06 Sep 2023 -
08:30 PM To 09:30 PM 
Certificate Available 
Online Click Here
- 757
Add to Calendar
09/06/2023 08:30 PM
09/06/2023 09:30 PM
Asia/ Riyadh
A New Treatment in Alopecia Areata
A New Treatment in Alopecia Areata
https://medicalacademy.org/portal/event/view/1995
